Home › Funds › GREAT POINT PARTNERS LLC › IMMX
GREAT POINT PARTNERS LLC position in IMMX
IMMIX BIOPHARMA INC COM · Health Care
GREAT POINT PARTNERS LLC reported holding 1,277,642 shares of IMMX (IMMIX BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$13.2M, representing 2.77% of its reported portfolio and ranking #15 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed IMMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's IMMX position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in IMMX in Q1 2026 at 350,000 shares (US$3.2M). The position peaked in Q2 2026 at 1,277,642 shares, worth US$13.2M. Across 2 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,277,642 shares valued at US$13.2M — an increase of 927,642 shares quarter over quarter.. Notable position changes include a 265% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 350.00K | $3.19M | New |
| Q2 2026 | 1.28M | $13.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC COM) is a Health Care company. 94 other funds we track also report a position in IMMX — the largest reported positions include Saturn V Capital Management LP (US$48.0M), Deep Track Capital, LP (US$28.6M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- Saturn V Capital Management LP 4.66M sh · $48.03M · Q2 2026
- Deep Track Capital, LP 2.77M sh · $28.61M · Q2 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.19M · Q2 2026
- Bleichroeder LP 1.00M sh · $10.31M · Q2 2026
- Logos Global Management LP 1.00M sh · $10.31M · Q2 2026
- Blue Owl Capital Holdings LP 437.55K sh · $4.51M · Q2 2026
- KVP Capital Advisors, LP 230.42K sh · $2.38M · Q2 2026
- Imprint Wealth LLC 26.23K sh · $270.46K · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held IMMX?
GREAT POINT PARTNERS LLC has disclosed IMMX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is GREAT POINT PARTNERS LLC's current position in IMMX?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 1.28M shares of IMMX (IMMIX BIOPHARMA INC COM), valued at $13.17M, representing 2.77% of its reported portfolio and ranking #15.
Has GREAT POINT PARTNERS LLC been buying or selling IMMX?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC increased its position in IMMX. The position peaked in Q2 2026 at 1.28M shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include Saturn V Capital Management LP, Deep Track Capital, LP, Opaleye Management Inc., among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.